Follow the people · Insider
Albert Luderer
Albert Luderer files insider transactions with the SEC as an interim chief executive of Bionano Genomics (BNGO). We hold 1 disclosed purchase or sale filed since 3 October 2018, 1 of them in the last 90 days.
- Files forBNGO
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure21 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 1 October 2018 — 21 August 2026Interim Chief Executive · Bionano Genomics (BNGO)11 Form 4 lines · source: SEC Form 4
Everything they disclosed
11 entries, newest first — one per disclosure report, one per Form 4 line- ▲ bought on the open market 4,000 shares of Bionano GenomicsSEC Form 421 August 2026Common Stock · traded 21 August 2026 · filed 21 August 2026
- was granted 2,775 shares of Bionano Genomics (a derivative holding)SEC Form 412 June 2025Stock Option (Right to Buy) · traded 11 June 2025 · filed 12 June 2025
- was granted 30,000 shares of Bionano Genomics (a derivative holding)SEC Form 420 June 2024Stock Option (Right to Buy) · traded 18 June 2024 · filed 20 June 2024
- was granted 250,000 shares of Bionano Genomics (a derivative holding)SEC Form 416 June 2023Stock Option (Right to Buy) · traded 14 June 2023 · filed 16 June 2023
- was granted 44,470 shares of Bionano Genomics (a derivative holding)SEC Form 418 July 2022Stock Option (Right to Buy) · traded 30 June 2020 · filed 18 July 2022
- was granted 164,422 shares of Bionano Genomics (a derivative holding)SEC Form 413 June 2022Stock Option (right to buy) · traded 9 June 2022 · filed 13 June 2022
- was granted 40,751 shares of Bionano Genomics (a derivative holding)SEC Form 419 August 2021Stock Option (right to buy) · traded 17 August 2021 · filed 19 August 2021
- was granted 7,528 shares of Bionano Genomics (a derivative holding)SEC Form 414 June 2021Stock Option (right to buy) · traded 10 June 2021 · filed 14 June 2021
- was granted 44,470 shares of Bionano Genomics (a derivative holding)SEC Form 42 July 2020Stock Option (right to buy) · traded 30 June 2020 · filed 2 July 2020
- was granted 21,911 shares of Bionano Genomics (a derivative holding)SEC Form 410 June 2019Stock Option (right to buy) · traded 6 June 2019 · filed 10 June 2019
- was granted 10,516 shares of BioNano Genomics (a derivative holding)SEC Form 43 October 2018Stock Option (Right to Buy) · traded 1 October 2018 · filed 3 October 2018
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.